Barriers to compliance with prophylaxis therapy in haemophilia

被引:234
|
作者
Hacker, MR [1 ]
Geraghty, S [1 ]
Manco-Johnson, M [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Mt States Reg Hemophilia & Thrombosis Ctr, Aurora, CO 80045 USA
关键词
children; compliance; haemophilia; prophylaxis;
D O I
10.1046/j.1365-2516.2001.00534.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prophylaxis, or the practice of routine replacement infusions of clotting factor concentrate in persons with severe haemophilia, is a demanding medical regimen. Prophylactic infusions require direct venepuncture or sterile entry into a central venous access device on a regular basis. A telephone survey was conducted to elicit information regarding the barriers to compliance with prophylaxis. The Mountain States Regional Haemophilia and Thrombosis Center has recommended prophylaxis to 52 male patients with haemophilia A or B. The haemophilia nurse attempted to contact all of these patients or their parents, and contact was made with 38 (73.1%) of them. Respondents were asked about the following issues: their decision to initiate prophylaxis; their self-rated compliance; the challenges, barriers, and facilitators of prophylaxis; and their perceived value of the therapy. Four patients (10.5%) elected not to begin prophylaxis. Of the 34 persons who began prophylaxis, 20 respondents (58.8%) rated their compliance as excellent. Nearly one-third of the families with excellent compliance (giving 75-100% of prescribed infusions) stated that the time-consuming nature of prophylaxis was the most significant challenge of the regimen. In addition, 58.3% of the families that gave less than the prescribed number of infusions reported that the time commitment was the primary reason for missing infusions. Knowledge of the benefits of prophylaxis was the primary facilitator of compliance for 44.1% of families. Ninety-seven percent of respondents rated prophylaxis as very valuable. These data show that despite the known benefits of prophylaxis, it is a demanding medical regimen, and compliance is imperfect. In addition, this study underscores the importance of providing continuing support and education for patients and families who are implementing prophylaxis.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 50 条
  • [41] Primary prophylaxis in haemophilia care: Guideline update 2016
    Fischer, Kathelijn
    Ljung, Rolf
    BLOOD CELLS MOLECULES AND DISEASES, 2017, 67 : 81 - 85
  • [42] Patterns of joint damage in severe haemophilia A treated with prophylaxis
    Goren, Rachel
    Pullenayegum, Eleanor
    Blanchette, Victor S.
    Dover, Saunya
    Carcao, Manuel
    Israels, Sara J.
    Chan, Anthony
    Rivard, Georges E.
    Steele, MacGregor
    Cloutier, Stephanie
    Klaassen, Robert J.
    Sinha, Roona
    Price, Victoria E.
    Laferriere, Nicole
    Paradis, Elizabeth
    Wu, John K.
    Feldman, Brian M.
    HAEMOPHILIA, 2021, 27 (04) : 666 - 673
  • [43] Primary prophylaxis with rFVIIa in a patient with severe haemophilia a and inhibitor
    Jimenez-Yuste, Victor
    Quintana, Manuel
    Alvarez, Maria Teresa
    Martin-Salces, Monica
    Hernandez-Navarro, Fernando
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (07) : 719 - 720
  • [44] A comparison between prophylaxis and on demand treatment for severe haemophilia
    Khoriaty, R
    Taher, A
    Inati, A
    Lee, C
    CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (05): : 320 - 323
  • [45] Guidelines for the prophylaxis of haemophilia A and B: new horizons and ambitions
    Hermans, Cedric
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (05) : 643 - 644
  • [46] Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study
    Schrijvers, LieSbeth H.
    Beijlevelt-van der Zande, Marlene
    Peters, Marjolein
    Lock, Janske
    Cnossen, Marjon H.
    Schuurmans, Marieke J.
    Fischer, Kathelijn
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (03) : 454 - 460
  • [47] Individualized PK-based prophylaxis in severe haemophilia
    Dargaud, Y.
    Delavenne, X.
    Hart, D. P.
    Meunier, S.
    Mismetti, P.
    HAEMOPHILIA, 2018, 24 : 3 - 17
  • [48] Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy
    Lindvall, K.
    Astermark, J.
    Bjorkman, S.
    Ljung, R.
    Carlsson, K. S.
    Persson, S.
    Berntorp, E.
    HAEMOPHILIA, 2012, 18 (06) : 855 - 859
  • [49] Physical activity and joint function in adults with severe haemophilia on long-term prophylaxis
    Khawaji, Mohamed
    Astermark, Jan
    Akesson, Kristina
    Berntorp, Erik
    BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (01) : 50 - 55
  • [50] Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia
    Nijdam, A.
    Foppen, W.
    van der Schouw, Y. T.
    Mauser-Bunschoten, E. P.
    Schutgens, R. E. G.
    Fischer, K.
    HAEMOPHILIA, 2016, 22 (06) : 852 - 858